Last $9.15 USD
Change Today -0.05 / -0.54%
Volume 178.8K
OSUR On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 11:22 AM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Douglas G. Watson

Chairman, Member of Audit Committee and Member of Compensation Committee, OraSure Technologies, Inc.
AgeTotal Calculated CompensationThis person is connected to 41 board members in 4 different organizations across 9 different industries.

See Board Relationships
69$193,999

Background*

Mr. Douglas G. Watson, also known as Doug, founded Pittencrieff Glen Associates in June 1999 and has been its Chief Executive Officer since July 1999. From June 2000 to September 2001, Mr. Watson served as the President and Chief Executive Officer of ValiGen N.V. His career spanned 33 years with Geigy and Ciba Geigy/Novartis, where he held a variety of positions in the U.K., Switzerland and the U.S. From January 1997 to May 1999, he served as the President and Chief ...

Read Full Background

Corporate Headquarters*

220 East First Street
Bethlehem, Pennsylvania 18015

United States

Phone: 610-882-1820
Fax: 610-882-1830

Board Members Memberships*

Former Director
Former Chairman, Chairman of Compensation Committee, Chairman of Audit Committee, Member of Corporate Governance Committee and Director of Innovative Drug Delivery Systems, Inc
Director
Chairman of the Board
1991-N/A
Former Director, Chairman of Audit Committee and Chairman of Nominating & Governance Committee
1996-N/A
Former Director
1999-Present
Director, Chairman of Nominating & Governance Committee and Member of Compensation Committee
2000-Present
Chairman, Chairman of Audit Committee and Member of Compensation Committee
2001-N/A
Former Director, Chairman of Sales & Marketing Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
2002-2011
Former Vice Chairman, Chairman of Compensation Committee, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
2002-Present
Chairman, Member of Audit Committee and Member of Compensation Committee
2003-N/A
Former Director
2004-N/A
Chairman, Chairman of Compensation Committee, Chairman of Corporate Governance & Nominating Committee, Chairman of Audit Committee and Director of IDDS
2004-N/A
Former Chairman of the Board, Member of Audit Committee, Member of Compensation Committee, Member of Corporate Governance Committee and Director of IDDS
2010-2014
Former Director, Member of Audit Committee and Member of Transition Committee
2013-Present
Director and Member of Nominating, Compliance & Governance Committee

Education*

MA
Churchill College, University of Cambridge
BA
Churchill College, University of Cambridge

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$74,000
Total Calculated Compensation$193,999
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OSUR:US $9.15 USD -0.05

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Douglas C. Bryant Chief Executive Officer, President and Director
Quidel Corp.
$509.1K
John A. Kraeutler Chief Executive Officer and Director
Meridian Bioscience, Inc.
$901.4K
Ronan O’Caoimh Co-Founder, Chairman, Chief Executive Officer and Chairman of Compensation Committee
Trinity Biotech plc
$877.0K
Craig A. Wheeler Chief Executive Officer, President and Executive Director
Momenta Pharmaceuticals Inc.
$621.0K
Douglas L. Drysdale Chairman, Chief Executive Officer and President
Pernix Therapeutics Holdings, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORASURE TECHNOLOGIES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.